Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Heather J. Logghe, MD, Tyler Rouse, MD, Alec Beekley, MD, and Rajesh Aggarwal, MD, PhD
Modern surgeons are diverse, socially adept, and differ in other important ways from the stereotype of a technically gifted white male with poor bedside manner.
AMA J Ethics. 2018;20(5):492-500. doi:
10.1001/journalofethics.2018.20.5.mhst1-1805.
Dr Chad M. Teven joins Ethics Talk to unravel some current and a few hoped-for surgical applications of AI and to model for us how we should be critically engaging with AI surgical research and scholarship.